Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119 | American Journal of PharmacoGenomics | journal | 1.106 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
118 | Drug Design Reviews Online | journal | 11 | 48 | 0 | 5344 | 0 | 0 | 0.00 | 111.33 | 35.04 | ||
117 | Letters in Drug Design and Discovery | journal | 37 | 99 | 0 | 4122 | 0 | 0 | 0.00 | 41.64 | 29.10 | ||
116 | Medicinal Chemistry Reviews - Online | journal | 7 | 46 | 0 | 5102 | 0 | 0 | 0.00 | 110.91 | 33.58 | ||
115 | Molecular Pain | journal | 96 | 36 | 0 | 1307 | 0 | 0 | 0.00 | 36.31 | 31.75 | ||
114 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 151 | 48 | 0 | 1539 | 0 | 0 | 0.00 | 32.06 | 30.00 | ||
113 | AIDS Research and Therapy | journal | 0.167 Q4 | 49 | 12 | 2 | 348 | 2 | 1 | 1.00 | 29.00 | 29.31 | |
112 | BMC Chemical Biology | journal | 0.261 Q4 | 21 | 3 | 4 | 102 | 4 | 4 | 1.33 | 34.00 | 33.33 | |
111 | Drugs Made in Germany | journal | 0.102 Q4 | 4 | 0 | 13 | 0 | 0 | 13 | 0.00 | 0.00 | 0.00 | |
110 | Drug Design and Discovery | journal | 0.291 Q4 | 20 | 0 | 16 | 0 | 18 | 16 | 1.42 | 0.00 | 0.00 | |
109 | Gene Therapy and Regulation | journal | 0.158 Q4 | 7 | 0 | 22 | 0 | 9 | 18 | 0.41 | 0.00 | 0.00 | |
108 | Journal of Nanobiotechnology | journal | 0.718 Q3 | 109 | 9 | 18 | 202 | 47 | 18 | 2.61 | 22.44 | 13.51 | |
107 | Genetic Vaccines and Therapy | journal | 1.154 Q2 | 30 | 8 | 20 | 343 | 58 | 19 | 2.90 | 42.88 | 43.10 | |
106 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.111 Q4 | 29 | 23 | 19 | 1464 | 4 | 19 | 0.00 | 63.65 | 12.50 | |
105 | Clinical Proteomics | journal | 0.598 Q3 | 42 | 0 | 20 | 0 | 37 | 20 | 1.85 | 0.00 | 0.00 | |
104 | Progress in Medicinal Chemistry | journal | 1.045 Q2 | 38 | 8 | 26 | 868 | 80 | 22 | 2.67 | 108.50 | 7.69 | |
103 | Cellular Oncology | journal | 0.462 Q4 | 44 | 34 | 29 | 1347 | 68 | 25 | 2.34 | 39.62 | 31.09 | |
102 | MCB Molecular and Cellular Biomechanics | journal | 0.315 Q4 | 31 | 20 | 25 | 727 | 28 | 25 | 1.12 | 36.35 | 22.92 | |
101 | Progress in Drug Research | book series | 1.063 Q2 | 46 | 23 | 39 | 2369 | 125 | 35 | 2.80 | 103.00 | 18.42 | |
100 | Human Genomics | journal | 1.921 Q1 | 68 | 22 | 43 | 868 | 117 | 42 | 2.72 | 39.45 | 32.20 | |
99 | Molecular Pharmaceutics | journal | 0.542 Q3 | 156 | 62 | 57 | 2124 | 128 | 53 | 2.25 | 34.26 | 27.75 | |
98 | Pteridines | journal | 0.198 Q4 | 19 | 13 | 54 | 381 | 20 | 54 | 0.44 | 29.31 | 25.49 | |
97 | Drug Discovery Today: Technologies | journal | 0.335 Q4 | 62 | 55 | 62 | 1688 | 68 | 61 | 1.10 | 30.69 | 24.37 | |
96 | Drug Discovery Today: Disease Mechanisms | journal | 0.156 Q4 | 28 | 81 | 65 | 3216 | 19 | 64 | 0.29 | 39.70 | 30.91 | |
95 | Drug Discovery Today: Disease Models | journal | 0.130 Q4 | 33 | 48 | 64 | 1909 | 8 | 64 | 0.13 | 39.77 | 32.48 | |
94 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.678 Q3 | 45 | 52 | 71 | 4786 | 125 | 65 | 1.90 | 92.04 | 22.13 | |
93 | Progress in Molecular Biology and Translational Science | journal | 3.912 Q1 | 113 | 17 | 66 | 3772 | 374 | 66 | 4.16 | 221.88 | 48.15 | |
92 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.430 Q4 | 39 | 29 | 74 | 3723 | 101 | 68 | 1.18 | 128.38 | 24.71 | |
91 | Molecular Imaging | journal | 1.489 Q1 | 66 | 49 | 72 | 1723 | 400 | 71 | 5.34 | 35.16 | 25.45 | |
90 | Pharmacological Reviews | journal | 9.872 Q1 | 254 | 30 | 73 | 5479 | 1707 | 71 | 16.30 | 182.63 | 19.05 | |
89 | Drug Discovery Today: Therapeutic Strategies | journal | 0.201 Q4 | 31 | 55 | 74 | 2069 | 38 | 73 | 0.51 | 37.62 | 27.18 | |
88 | Medicinal Research Reviews | journal | 2.935 Q1 | 150 | 29 | 80 | 3798 | 789 | 80 | 9.22 | 130.97 | 33.07 | |
87 | Journal of Experimental Zoology Part B: Molecular and Developmental Evolution | journal | 1.098 Q2 | 70 | 49 | 84 | 3897 | 242 | 81 | 2.88 | 79.53 | 35.45 | |
86 | Molecular Aspects of Medicine | journal | 2.182 Q1 | 159 | 28 | 85 | 2496 | 561 | 81 | 6.44 | 89.14 | 25.45 | |
85 | Molecular Cancer | journal | 1.729 Q1 | 196 | 43 | 87 | 1999 | 340 | 81 | 3.76 | 46.49 | 31.74 | |
84 | Advances in Biological Regulation | journal | 1.035 Q2 | 69 | 19 | 83 | 948 | 153 | 82 | 1.73 | 49.89 | 31.17 | |
83 | Expert Reviews in Molecular Medicine | journal | 0.659 Q3 | 93 | 29 | 84 | 3714 | 185 | 84 | 1.71 | 128.07 | 34.29 | |
82 | Infectious Disorders - Drug Targets | journal | 0.992 Q2 | 61 | 31 | 94 | 4786 | 277 | 87 | 2.64 | 154.39 | 28.40 | |
81 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.156 Q4 | 40 | 14 | 90 | 364 | 21 | 90 | 0.12 | 26.00 | 25.45 | |
80 | NeuroMolecular Medicine | journal | 2.244 Q1 | 82 | 24 | 97 | 2375 | 442 | 94 | 4.64 | 98.96 | 27.69 | |
79 | Drugs under Experimental and Clinical Research | journal | 0.403 Q4 | 41 | 36 | 102 | 879 | 156 | 102 | 1.43 | 24.42 | 41.53 | |
78 | Current Gene Therapy | journal | 1.077 Q2 | 80 | 58 | 114 | 6023 | 467 | 112 | 3.65 | 103.84 | 32.78 | |
77 | OMICS A Journal of Integrative Biology | journal | 0.946 Q3 | 69 | 31 | 122 | 1094 | 298 | 112 | 2.16 | 35.29 | 31.72 | |
76 | Nucleic Acid Therapeutics | journal | 1.368 Q2 | 77 | 28 | 121 | 875 | 484 | 114 | 3.99 | 31.25 | 34.71 | |
75 | Journal of Trace Elements in Medicine and Biology | journal | 0.283 Q4 | 92 | 47 | 119 | 1523 | 140 | 117 | 1.09 | 32.40 | 36.75 | |
74 | Journal of Molecular Diagnostics | journal | 1.022 Q2 | 111 | 81 | 120 | 2436 | 347 | 118 | 2.97 | 30.07 | 34.60 | |
73 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.425 Q2 | 108 | 47 | 129 | 5410 | 529 | 122 | 3.39 | 115.11 | 27.78 | |
72 | Journal of Biochemical and Molecular Toxicology | journal | 0.751 Q3 | 69 | 56 | 122 | 2056 | 268 | 122 | 2.29 | 36.71 | 41.49 | |
71 | International Journal of Peptide Research and Therapeutics | journal | 0.310 Q4 | 45 | 29 | 136 | 1079 | 59 | 134 | 0.30 | 37.21 | 38.94 | |
70 | Molecular Medicine | journal | 1.672 Q1 | 133 | 9 | 135 | 701 | 564 | 134 | 3.43 | 77.89 | 42.86 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®